Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Shanghai Bio-heart Biological Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 400.83%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Shanghai Bio-heart Biological Technology Co (HKSE:02185) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Shanghai Bio-heart Biological Technology Co 3-Year ROIIC % Related Terms
Shanghai Bio-heart Biological Technology Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Bio-heart Biological Technology Co 3-Year ROIIC % Chart
Shanghai Bio-heart Biological Technology Co Annual Data
HKSE:02185 vs VRTX, REGN, MRNA: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Shanghai Bio-heart Biological Technology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Bio-heart Biological Technology Co 3-Year ROIIC % vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Shanghai Bio-heart Biological Technology Co (HKSE:02185) has a 3-Year ROIIC % of 400.83 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shanghai Bio-heart Biological Technology Co and its competitors. This is 31% above median its historical median of 304.86. According to the industry distribution chart, Shanghai Bio-heart Biological Technology Co ranks #131 out of 1310 companies in the Biotechnology industry, placing it in the top 10%.
Is Shanghai Bio-heart Biological Technology Co's 3-Year ROIIC % too high?
Shanghai Bio-heart Biological Technology Co's current 3-Year ROIIC % of 400.83 is 31% above median its 10-year median of 304.86. Based on the distribution chart, Shanghai Bio-heart Biological Technology Co ranks #131 out of 1310 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Bio-heart Biological Technology Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Bio-heart Biological Technology Co's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Bio-heart Biological Technology Co ranks #131 out of 1310 companies for 3-Year ROIIC %. This places Shanghai Bio-heart Biological Technology Co in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shanghai Bio-heart Biological Technology Co and its competitors. Shanghai Bio-heart Biological Technology Co's current 3-Year ROIIC % is 400.83, which is 31% above median its own 10-year median of 304.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Bio-heart Biological Technology Co stock overvalued right now?
Shanghai Bio-heart Biological Technology Co (HKSE:02185) has a current 3-Year ROIIC % of 400.83. The current 3-Year ROIIC % is 400.83, which is 31% above median its 10-year median of 304.86. Shanghai Bio-heart Biological Technology Co's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Shanghai Bio-heart Biological Technology Co (HKSE:02185), the current 3-Year ROIIC % is 400.83 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Currently, the portfolio has three product candidates in various stages of clinical development.
23GF Score
Get the complete analysis for HKSE:02185
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02185 has been successfully added to your 
